Chat with us, powered by LiveChat


Global Cardiac Marker Testing Market Size, Share, Growth Trends and Competitive Analysis 2023-2029

Global Cardiac Marker Testing Market Size, Share, Growth Trends and Competitive Analysis 2023-2029
Report Category: Pharma and Healthcare
SKU: PMR-120800  Published Date: 2023-11-02   Pages:114   Delivery Format:


CHOOSE LICENSE TYPE





PMR Research.

Market Executive Summary

Due to the COVID-19 pandemic, the global Cardiac Marker Testing market size was US$ 2462.1 million in 2022 and is forecast to a readjusted size of US$ 3569.4 million by 2029 with a CAGR of 5.0% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Chemiluminescence accounting for % of the Cardiac Marker Testing global market in 2022, is projected to value US$ million by 2029, growing at a revised ?GR from 2023 to 2029. While Pharmaceutical Companies segment is altered to an ?GR throughout this forecast period.

The global key companies of Cardiac Marker Testing include Roche Diagnostics, Abbott Laboratories, Siemens, Danaher Corporation, Alere Inc, BioMerieux, LSI Medience Corporation, Ortho Clinical Diagnostics and Randox Laboratories Ltd, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

The United States Cardiac Marker Testing market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2029, trailing a CAGR of % through the analysis period. As for the Europe Cardiac Marker Testing landscape, Germany is projected to reach US$ million by 2029. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Cardiac Marker Testing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Cardiac Marker Testing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Cardiac Marker Testing market. Readers of the report can become informed about current and future trends of the global Cardiac Marker Testing market and how they will impact market growth during the forecast period.

By Company

    Roche Diagnostics

    Abbott Laboratories

    Siemens

    Danaher Corporation

    Alere Inc

    BioMerieux

    LSI Medience Corporation

    Ortho Clinical Diagnostics

    Randox Laboratories Ltd

    Guangzhou Wondfo Biotech

Segment by Type

    Chemiluminescence

    Immunofluorescence

    ELISA

    Immunochromatography

    Others

Segment by Application

    Pharmaceutical Companies

    Reagents Manufacturers

    Imaging Instrument Providers

    Others

By Region

    North America


        U.S.

        Canada

    Europe

        Germany

        France

        U.K.

        Italy

        Russia

    Asia-Pacific

        China

        Japan

        South Korea

        India

        Australia

        China Taiwan

        Indonesia

    Latin America

        Mexico

        Brazil

        Argentina

    Middle East & Africa

        Turkey

        Saudi Arabia

        UAE

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.

Chapter 2: Revenue of Cardiac Marker Testing in global and regional level.

Chapter 3: Detailed analysis of Cardiac Marker Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.

Chapter 9: Latin America by type, by application and by country, revenue for each segment.

Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cardiac Marker Testing revenue, gross margin, and recent development, etc.

Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 13: Research Findings and Conclusion



Table of Contents

1 Report Overview

    1.1 Study Scope

    1.2 Market Analysis by Type

        1.2.1 Global Cardiac Marker Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

        1.2.2 Chemiluminescence

        1.2.3 Immunofluorescence

        1.2.4 ELISA

        1.2.5 Immunochromatography

        1.2.6 Others

    1.3 Market by Application

        1.3.1 Global Cardiac Marker Testing Market Growth Rate by Application: 2018 VS 2022 VS 2029

        1.3.2 Pharmaceutical Companies

        1.3.3 Reagents Manufacturers

        1.3.4 Imaging Instrument Providers

        1.3.5 Others

    1.4 Assumptions and Limitations

    1.5 Study Objectives

    1.6 Years Considered

 2 Market Perspective

    2.1 Global Cardiac Marker Testing Market Size (2018-2029)

    2.2 Cardiac Marker Testing Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2029

    2.3 Global Cardiac Marker Testing Market Size by Region (2018-2023)

    2.4 Global Cardiac Marker Testing Market Size Forecast by Region (2024-2029)

    2.5 Global Top 10 Cardiac Marker Testing Countries Ranking by Market Size

 3 Cardiac Marker Testing Competitive by Company

    3.1 Global Cardiac Marker Testing Revenue by Players

        3.1.1 Global Cardiac Marker Testing Revenue by Players (2018-2023)

        3.1.2 Global Cardiac Marker Testing Market Share by Players (2018-2023)

    3.2 Global Cardiac Marker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

    3.3 Company Covered: Ranking by Cardiac Marker Testing Revenue

    3.4 Global Cardiac Marker Testing Market Concentration Ratio

        3.4.1 Global Cardiac Marker Testing Market Concentration Ratio (CR5 and HHI)

        3.4.2 Global Top 10 and Top 5 Companies by Cardiac Marker Testing Revenue in 2022

    3.5 Global Key Players of Cardiac Marker Testing Head office and Area Served

    3.6 Global Key Players of Cardiac Marker Testing, Product and Application

    3.7 Global Key Players of Cardiac Marker Testing, Date of Enter into This Industry

    3.8 Mergers & Acquisitions, Expansion Plans

 4 Global Cardiac Marker Testing Breakdown Data by Type

    4.1 Global Cardiac Marker Testing Historic Revenue by Type (2018-2023)

    4.2 Global Cardiac Marker Testing Forecasted Revenue by Type (2024-2029)

 5 Global Cardiac Marker Testing Breakdown Data by Application

    5.1 Global Cardiac Marker Testing Historic Market Size by Application (2018-2023)

    5.2 Global Cardiac Marker Testing Forecasted Market Size by Application (2024-2029)

 6 North America

    6.1 North America Cardiac Marker Testing Revenue by Company (2021-2023)

    6.2 North America Cardiac Marker Testing Revenue by Type (2018-2029)

    6.3 North America Cardiac Marker Testing Revenue by Application (2018-2029)

    6.4 North America Cardiac Marker Testing Revenue by Country (2018-2029)

        6.4.1 U.S.

        6.4.2 Canada

 7 Europe

    7.1 Europe Cardiac Marker Testing Revenue by Company (2021-2023)

    7.2 Europe Cardiac Marker Testing Revenue by Type (2018-2029)

    7.3 Europe Cardiac Marker Testing Revenue by Application (2018-2029)

    7.4 Europe Cardiac Marker Testing Revenue by Country (2018-2029)

        7.4.1 Germany

        7.4.2 France

        7.4.3 U.K.

        7.4.4 Italy

        7.4.5 Russia

 8 Asia Pacific

    8.1 Asia Pacific Cardiac Marker Testing Revenue by Company (2021-2023)

    8.2 Asia Pacific Cardiac Marker Testing Revenue by Type (2018-2029)

    8.3 Asia Pacific Cardiac Marker Testing Revenue by Application (2018-2029)

    8.4 Asia Pacific Cardiac Marker Testing Revenue by Region (2018-2029)

        8.4.1 China

        8.4.2 Japan

        8.4.3 South Korea

        8.4.4 India

        8.4.5 Australia

        8.4.6 China Taiwan

        8.4.7 Indonesia

        8.4.8 Thailand

        8.4.9 Malaysia

 9 Latin America

    9.1 Latin America Cardiac Marker Testing Revenue by Company (2021-2023)

    9.2 Latin America Cardiac Marker Testing Revenue by Type (2018-2029)

    9.3 Latin America Cardiac Marker Testing Revenue by Application (2018-2029)

    9.4 Latin America Cardiac Marker Testing Revenue by Country (2018-2029)

        9.4.1 Mexico

        9.4.2 Brazil

        9.4.3 Argentina

 10 Middle East and Africa

    10.1 Middle East and Africa Cardiac Marker Testing Revenue by Company (2021-2023)

    10.2 Middle East and Africa Cardiac Marker Testing Revenue by Type (2018-2029)

    10.3 Middle East and Africa Cardiac Marker Testing Revenue by Application (2018-2029)

    10.4 Middle East and Africa Cardiac Marker Testing Revenue by Country (2018-2029)

        10.4.1 Turkey

        10.4.2 Saudi Arabia

        10.4.3 UAE

 11 Company Profiles

    11.1 Roche Diagnostics

        11.1.1 Roche Diagnostics Company Details

        11.1.2 Roche Diagnostics Business Overview

        11.1.3 Roche Diagnostics Cardiac Marker Testing Products and Services

        11.1.4 Roche Diagnostics Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023)

        11.1.5 Roche Diagnostics Cardiac Marker Testing SWOT Analysis

        11.1.6 Roche Diagnostics Recent Development

    11.2 Abbott Laboratories

        11.2.1 Abbott Laboratories Company Details

        11.2.2 Abbott Laboratories Business Overview

        11.2.3 Abbott Laboratories Cardiac Marker Testing Products and Services

        11.2.4 Abbott Laboratories Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023)

        11.2.5 Abbott Laboratories Cardiac Marker Testing SWOT Analysis

        11.2.6 Abbott Laboratories Recent Development

    11.3 Siemens

        11.3.1 Siemens Company Details

        11.3.2 Siemens Business Overview

        11.3.3 Siemens Cardiac Marker Testing Products and Services

        11.3.4 Siemens Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023)

        11.3.5 Siemens Cardiac Marker Testing SWOT Analysis

        11.3.6 Siemens Recent Development

    11.4 Danaher Corporation

        11.4.1 Danaher Corporation Company Details

        11.4.2 Danaher Corporation Business Overview

        11.4.3 Danaher Corporation Cardiac Marker Testing Products and Services

        11.4.4 Danaher Corporation Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023)

        11.4.5 Danaher Corporation Cardiac Marker Testing SWOT Analysis

        11.4.6 Danaher Corporation Recent Development

    11.5 Alere Inc

        11.5.1 Alere Inc Company Details

        11.5.2 Alere Inc Business Overview

        11.5.3 Alere Inc Cardiac Marker Testing Products and Services

        11.5.4 Alere Inc Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023)

        11.5.5 Alere Inc Cardiac Marker Testing SWOT Analysis

        11.5.6 Alere Inc Recent Development

    11.6 BioMerieux

        11.6.1 BioMerieux Company Details

        11.6.2 BioMerieux Business Overview

        11.6.3 BioMerieux Cardiac Marker Testing Products and Services

        11.6.4 BioMerieux Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023)

        11.6.5 BioMerieux Cardiac Marker Testing SWOT Analysis

        11.6.6 BioMerieux Recent Development

    11.7 LSI Medience Corporation

        11.7.1 LSI Medience Corporation Company Details

        11.7.2 LSI Medience Corporation Business Overview

        11.7.3 LSI Medience Corporation Cardiac Marker Testing Products and Services

        11.7.4 LSI Medience Corporation Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023)

        11.7.5 LSI Medience Corporation Cardiac Marker Testing SWOT Analysis

        11.7.6 LSI Medience Corporation Recent Development

    11.8 Ortho Clinical Diagnostics

        11.8.1 Ortho Clinical Diagnostics Company Details

        11.8.2 Ortho Clinical Diagnostics Business Overview

        11.8.3 Ortho Clinical Diagnostics Cardiac Marker Testing Products and Services

        11.8.4 Ortho Clinical Diagnostics Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023)

        11.8.5 Ortho Clinical Diagnostics Cardiac Marker Testing SWOT Analysis

        11.8.6 Ortho Clinical Diagnostics Recent Development

    11.9 Randox Laboratories Ltd

        11.9.1 Randox Laboratories Ltd Company Details

        11.9.2 Randox Laboratories Ltd Business Overview

        11.9.3 Randox Laboratories Ltd Cardiac Marker Testing Products and Services

        11.9.4 Randox Laboratories Ltd Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023)

        11.9.5 Randox Laboratories Ltd Cardiac Marker Testing SWOT Analysis

        11.9.6 Randox Laboratories Ltd Recent Development

    11.10 Guangzhou Wondfo Biotech

        11.10.1 Guangzhou Wondfo Biotech Company Details

        11.10.2 Guangzhou Wondfo Biotech Business Overview

        11.10.3 Guangzhou Wondfo Biotech Cardiac Marker Testing Products and Services

        11.10.4 Guangzhou Wondfo Biotech Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023)

        11.10.5 Guangzhou Wondfo Biotech Cardiac Marker Testing SWOT Analysis

        11.10.6 Guangzhou Wondfo Biotech Recent Development

 12 Cardiac Marker Testing Market Dynamics

    12.1 Cardiac Marker Testing Industry Trends

    12.2 Cardiac Marker Testing Market Drivers

    12.3 Cardiac Marker Testing Market Challenges

    12.4 Cardiac Marker Testing Market Restraints

 13 Research Findings and Conclusion

 14 Appendix

    14.1 Research Methodology

        14.1.1 Methodology/Research Approach

        14.1.2 Data Source

    14.2 Author Details



List of Figures

List of Tables

    Table 1. Global Cardiac Marker Testing Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2029

    Table 2. Key Players of Chemiluminescence

    Table 3. Key Players of Immunofluorescence

    Table 4. Key Players of ELISA

    Table 5. Key Players of Immunochromatography

    Table 6. Key Players of Others

    Table 7. Global Cardiac Marker Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

    Table 8. Global Cardiac Marker Testing Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

    Table 9. Global Cardiac Marker Testing Revenue by Region (2018-2023) & (US$ Million)

    Table 10. Global Cardiac Marker Testing Revenue Forecast by Region (2024-2029) & (US$ Million)

    Table 11. Global Cardiac Marker Testing Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)

    Table 12. Global Cardiac Marker Testing Revenue by Players (2018-2023) & (US$ Million)

    Table 13. Global Cardiac Marker Testing Market Share by Players (2018-2023)

    Table 14. Global Top Cardiac Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Marker Testing as of 2022)

    Table 15. Ranking of Global Top Cardiac Marker Testing Companies by Revenue (US$ Million) in 2022

    Table 16. Global 5 Largest Players Market Share by Cardiac Marker Testing Revenue (CR5 and HHI) & (2018-2023)

    Table 17. Global Key Players of Cardiac Marker Testing, Headquarters and Area Served

    Table 18. Global Key Players of Cardiac Marker Testing, Product and Application

    Table 19. Global Key Players of Cardiac Marker Testing, Date of Enter into This Industry

    Table 20. Mergers & Acquisitions, Expansion Plans

    Table 21. Global Cardiac Marker Testing Market Size by Type (2018-2023) & (US$ Million)

    Table 22. Global Cardiac Marker Testing Revenue Market Share by Type (2018-2023)

    Table 23. Global Cardiac Marker Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 24. Global Cardiac Marker Testing Revenue Market Share by Type (2024-2029)

    Table 25. Global Cardiac Marker Testing Market Size by Application (2018-2023) & (US$ Million)

    Table 26. Global Cardiac Marker Testing Revenue Market Share by Application (2018-2023)

    Table 27. Global Cardiac Marker Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 28. Global Cardiac Marker Testing Revenue Market Share by Application (2024-2029)

    Table 29. North America Cardiac Marker Testing Revenue by Company (2021-2023) & (US$ Million)

    Table 30. North America Cardiac Marker Testing Revenue by Type (2018-2023) & (US$ Million)

    Table 31. North America Cardiac Marker Testing Revenue by Type (2024-2029) & (US$ Million)

    Table 32. North America Cardiac Marker Testing Revenue by Application (2018-2023) & (US$ Million)

    Table 33. North America Cardiac Marker Testing Revenue by Application (2024-2029) & (US$ Million)

    Table 34. North America Cardiac Marker Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Cardiac Marker Testing Revenue by Country (2018-2023) & (US$ Million)

    Table 36. North America Cardiac Marker Testing Revenue by Country (2024-2029) & (US$ Million)

    Table 37. Europe Cardiac Marker Testing Revenue by Company (2021-2023) & (US$ Million)

    Table 38. Europe Cardiac Marker Testing Revenue by Type (2018-2023) & (US$ Million)

    Table 39. Europe Cardiac Marker Testing Revenue by Type (2024-2029) & (US$ Million)

    Table 40. Europe Cardiac Marker Testing Revenue by Application (2018-2023) & (US$ Million)

    Table 41. Europe Cardiac Marker Testing Revenue by Application (2024-2029) & (US$ Million)

    Table 42. Europe Cardiac Marker Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Europe Cardiac Marker Testing Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Europe Cardiac Marker Testing Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Asia Pacific Cardiac Marker Testing Revenue by Company (2021-2023) & (US$ Million)

    Table 46. Asia Pacific Cardiac Marker Testing Revenue by Type (2018-2023) & (US$ Million)

    Table 47. Asia Pacific Cardiac Marker Testing Revenue by Type (2024-2029) & (US$ Million)

    Table 48. Asia Pacific Cardiac Marker Testing Revenue by Application (2018-2023) & (US$ Million)

    Table 49. Asia Pacific Cardiac Marker Testing Revenue by Application (2024-2029) & (US$ Million)

    Table 50. Asia-Pacific Cardiac Marker Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 51. Asia Pacific Cardiac Marker Testing Revenue by Region (2018-2023) & (US$ Million)

    Table 52. Asia Pacific Cardiac Marker Testing Revenue by Region (2024-2029) & (US$ Million)

    Table 53. Latin America Cardiac Marker Testing Revenue by Company (2021-2023) & (US$ Million)

    Table 54. Latin America Cardiac Marker Testing Revenue by Type (2018-2023) & (US$ Million)

    Table 55. Latin America Cardiac Marker Testing Revenue by Type (2024-2029) & (US$ Million)

    Table 56. Latin America Cardiac Marker Testing Revenue by Application (2018-2023) & (US$ Million)

    Table 57. Latin America Cardiac Marker Testing Revenue by Application (2024-2029) & (US$ Million)

    Table 58. Latin America Cardiac Marker Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 59. Latin America Cardiac Marker Testing Revenue by Country (2018-2023) & (US$ Million)

    Table 60. Latin America Cardiac Marker Testing Revenue by Country (2024-2029) & (US$ Million)

    Table 61. Middle East and Africa Cardiac Marker Testing Revenue by Company (2021-2023) & (US$ Million)

    Table 62. Middle East and Africa Cardiac Marker Testing Revenue by Type (2018-2023) & (US$ Million)

    Table 63. Middle East and Africa Cardiac Marker Testing Revenue by Type (2024-2029) & (US$ Million)

    Table 64. Middle East and Africa Cardiac Marker Testing Revenue by Application (2018-2023) & (US$ Million)

    Table 65. Middle East and Africa Cardiac Marker Testing Revenue by Application (2024-2029) & (US$ Million)

    Table 66. Middle East and Africa Cardiac Marker Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 67. Middle East and Africa Cardiac Marker Testing Revenue by Country (2018-2023) & (US$ Million)

    Table 68. Middle East and Africa Cardiac Marker Testing Revenue by Country (2024-2029) & (US$ Million)

    Table 69. Roche Diagnostics Company Details

    Table 70. Roche Diagnostics Business Overview

    Table 71. Roche Diagnostics Cardiac Marker Testing Product and Services

    Table 72. Roche Diagnostics Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)

    Table 73. Roche Diagnostics Cardiac Marker Testing SWOT Analysis

    Table 74. Roche Diagnostics Recent Development

    Table 75. Abbott Laboratories Company Details

    Table 76. Abbott Laboratories Business Overview

    Table 77. Abbott Laboratories Cardiac Marker Testing Product and Services

    Table 78. Abbott Laboratories Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)

    Table 79. Abbott Laboratories Cardiac Marker Testing SWOT Analysis

    Table 80. Abbott Laboratories Recent Development

    Table 81. Siemens Company Details

    Table 82. Siemens Business Overview

    Table 83. Siemens Cardiac Marker Testing Product and Services

    Table 84. Siemens Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)

    Table 85. Siemens Cardiac Marker Testing SWOT Analysis

    Table 86. Siemens Recent Development

    Table 87. Danaher Corporation Company Details

    Table 88. Danaher Corporation Business Overview

    Table 89. Danaher Corporation Cardiac Marker Testing Product and Services

    Table 90. Danaher Corporation Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)

    Table 91. Danaher Corporation Cardiac Marker Testing SWOT Analysis

    Table 92. Danaher Corporation Recent Development

    Table 93. Alere Inc Company Details

    Table 94. Alere Inc Business Overview

    Table 95. Alere Inc Cardiac Marker Testing Product and Services

    Table 96. Alere Inc Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)

    Table 97. Alere Inc Cardiac Marker Testing SWOT Analysis

    Table 98. Alere Inc Recent Development

    Table 99. BioMerieux Company Details

    Table 100. BioMerieux Business Overview

    Table 101. BioMerieux Cardiac Marker Testing Product and Services

    Table 102. BioMerieux Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)

    Table 103. BioMerieux Cardiac Marker Testing SWOT Analysis

    Table 104. BioMerieux Recent Development

    Table 105. LSI Medience Corporation Company Details

    Table 106. LSI Medience Corporation Business Overview

    Table 107. LSI Medience Corporation Cardiac Marker Testing Product and Services

    Table 108. LSI Medience Corporation Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)

    Table 109. LSI Medience Corporation Cardiac Marker Testing SWOT Analysis

    Table 110. LSI Medience Corporation Recent Development

    Table 111. Ortho Clinical Diagnostics Company Details

    Table 112. Ortho Clinical Diagnostics Business Overview

    Table 113. Ortho Clinical Diagnostics Cardiac Marker Testing Product and Services

    Table 114. Ortho Clinical Diagnostics Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)

    Table 115. Ortho Clinical Diagnostics Cardiac Marker Testing SWOT Analysis

    Table 116. Ortho Clinical Diagnostics Recent Development

    Table 117. Randox Laboratories Ltd Company Details

    Table 118. Randox Laboratories Ltd Business Overview

    Table 119. Randox Laboratories Ltd Cardiac Marker Testing Product and Services

    Table 120. Randox Laboratories Ltd Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)

    Table 121. Randox Laboratories Ltd Cardiac Marker Testing SWOT Analysis

    Table 122. Randox Laboratories Ltd Recent Development

    Table 123. Guangzhou Wondfo Biotech Company Details

    Table 124. Guangzhou Wondfo Biotech Business Overview

    Table 125. Guangzhou Wondfo Biotech Cardiac Marker Testing Product and Services

    Table 126. Guangzhou Wondfo Biotech Cardiac Marker Testing Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)

    Table 127. Guangzhou Wondfo Biotech Cardiac Marker Testing SWOT Analysis

    Table 128. Guangzhou Wondfo Biotech Recent Development

    Table 129. Cardiac Marker Testing Market Trends

    Table 130. Cardiac Marker Testing Market Drivers

    Table 131. Cardiac Marker Testing Market Challenges

    Table 132. Cardiac Marker Testing Market Restraints

    Table 133. Research Programs/Design for This Report

    Table 134. Key Data Information from Secondary Sources

    Table 135. Key Data Information from Primary Sources

List of Figures

    Figure 1. Cardiac Marker Testing Product Picture

    Figure 2. Global Cardiac Marker Testing Market Size by Type (US$ Million): 2018 VS 2022 VS 2029

    Figure 3. Global Cardiac Marker Testing Market Share by Type: 2022 VS 2029

    Figure 4. Chemiluminescence Features

    Figure 5. Immunofluorescence Features

    Figure 6. ELISA Features

    Figure 7. Immunochromatography Features

    Figure 8. Others Features

    Figure 9. Global Cardiac Marker Testing Market Size by Application (US$ Million): 2018 VS 2022 VS 2029

    Figure 10. Global Cardiac Marker Testing Market Share by Application: 2022 VS 2029

    Figure 11. Pharmaceutical Companies

    Figure 12. Reagents Manufacturers

    Figure 13. Imaging Instrument Providers

    Figure 14. Others

    Figure 15. Cardiac Marker Testing Report Years Considered

    Figure 16. Global Cardiac Marker Testing Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Cardiac Marker Testing Market Size 2018-2029 (US$ Million)

    Figure 18. Global Cardiac Marker Testing Market Size Market Share by Region: 2022 VS 2029

    Figure 19. Global Cardiac Marker Testing Revenue Market Share by Region in 2018 VS 2022

    Figure 20. Global Cardiac Marker Testing Revenue Market Share Forecast by Region (2024-2029)

    Figure 21. Global Top 10 Cardiac Marker Testing Countries Ranking by Market Size (US$ Million) in 2022

    Figure 22. Global Cardiac Marker Testing Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)

    Figure 23. Global Cardiac Marker Testing Market Share by Players in 2022

    Figure 24. Global Top Cardiac Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Marker Testing as of 2022)

    Figure 25. The Top 10 and 5 Players Market Share by Cardiac Marker Testing Revenue in 2022

    Figure 26. North America Cardiac Marker Testing Revenue Market Share by Company in 2022

    Figure 27. North America Cardiac Marker Testing Revenue Market Share by Type (2018-2029)

    Figure 28. North America Cardiac Marker Testing Revenue Market Share by Application (2018-2029)

    Figure 29. North America Cardiac Marker Testing Revenue Share by Country (2018-2029)

    Figure 30. U.S. Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 31. Canada Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 32. Europe Cardiac Marker Testing Revenue Market Share by Company in 2022

    Figure 33. Europe Cardiac Marker Testing Revenue Market Share by Type (2018-2029)

    Figure 34. Europe Cardiac Marker Testing Revenue Market Share by Application (2018-2029)

    Figure 35. Europe Cardiac Marker Testing Revenue Share by Country (2018-2029)

    Figure 36. Germany Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 37. France Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 38. U.K. Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 39. Italy Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 40. Russia Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 41. Asia Pacific Cardiac Marker Testing Revenue Market Share by Company in 2022

    Figure 42. Asia Pacific Cardiac Marker Testing Revenue Market Share by Type (2018-2029)

    Figure 43. Asia Pacific Cardiac Marker Testing Revenue Market Share by Application (2018-2029)

    Figure 44. Asia Pacific Cardiac Marker Testing Revenue Share by Region (2018-2029)

    Figure 45. China Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 46. Japan Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 47. South Korea Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 48. India Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 49. Australia Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 50. China Taiwan Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 51. Indonesia Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 52. Thailand Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 53. Malaysia Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 54. Latin America Cardiac Marker Testing Revenue Market Share by Company in 2022

    Figure 55. Latin America Cardiac Marker Testing Revenue Market Share by Type (2018-2029)

    Figure 56. Latin America Cardiac Marker Testing Revenue Market Share by Application (2018-2029)

    Figure 57. Latin America Cardiac Marker Testing Revenue Share by Country (2018-2029)

    Figure 58. Mexico Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 59. Brazil Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 60. Argentina Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 61. Middle East and Africa Cardiac Marker Testing Revenue Market Share by Company in 2022

    Figure 62. Middle East and Africa Cardiac Marker Testing Revenue Market Share by Type (2018-2029)

    Figure 63. Middle East and Africa Cardiac Marker Testing Revenue Market Share by Application (2018-2029)

    Figure 64. Middle East and Africa Cardiac Marker Testing Revenue Share by Country (2018-2029)

    Figure 65. Turkey Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 66. Saudi Arabia Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 67. UAE Cardiac Marker Testing Revenue (2018-2029) & (US$ Million)

    Figure 68. Roche Diagnostics Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)

    Figure 69. Abbott Laboratories Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)

    Figure 70. Siemens Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)

    Figure 71. Danaher Corporation Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)

    Figure 72. Alere Inc Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)

    Figure 73. BioMerieux Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)

    Figure 74. LSI Medience Corporation Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)

    Figure 75. Ortho Clinical Diagnostics Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)

    Figure 76. Randox Laboratories Ltd Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)

    Figure 77. Guangzhou Wondfo Biotech Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)

    Figure 78. Bottom-up and Top-down Approaches for This Report

    Figure 79. Data Triangulation

    Figure 80. Key Executives Interviewed


We can offer customized data and information to meet our clients need.

This report focuses on:

► Intelligent insights to take informed business decisions.

► Qualitative and quantitative analysis of the market.

► Market size and forecasts from 2024 to 2030.

► Opportunities for expansion and in-depth market analysis.

► Segmentation and regional revenue forecasts.

► Analysis of the market share and competitive landscape.

► Strategic recommendations for future growth.


You'll also receive:

► A comprehensive market research report in PDF or PPT formats.

► Access to our analysts to learn more about the report and get answers to your specific business questions.

► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.


Contact us today to learn more and get sample report.


Our Research Reports Look Like This
Pragma Market Research Sample

Covid-19 Impact Duns and Brad Badge
up